Selective overshoot of Ph-negative blood hemopoietic cells after intensive idarubicin-containing regimen and their repopulating capacity after reinfusion.
Carella, A M
Selective overshoot of Ph-negative blood hemopoietic cells after intensive idarubicin-containing regimen and their repopulating capacity after reinfusion. [electronic resource] - Stem cells (Dayton, Ohio) Oct 1993 - 67-72 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1066-5099
10.1002/stem.5530110917 doi
Adult
Blast Crisis--therapy
Bone Marrow Transplantation
Combined Modality Therapy
Female
Hematopoietic Stem Cell Transplantation
Hematopoietic Stem Cells--pathology
Humans
Idarubicin--therapeutic use
Leukapheresis
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy
Leukemia, Myeloid, Accelerated Phase--blood
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative--blood
Male
Middle Aged
Selective overshoot of Ph-negative blood hemopoietic cells after intensive idarubicin-containing regimen and their repopulating capacity after reinfusion. [electronic resource] - Stem cells (Dayton, Ohio) Oct 1993 - 67-72 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1066-5099
10.1002/stem.5530110917 doi
Adult
Blast Crisis--therapy
Bone Marrow Transplantation
Combined Modality Therapy
Female
Hematopoietic Stem Cell Transplantation
Hematopoietic Stem Cells--pathology
Humans
Idarubicin--therapeutic use
Leukapheresis
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy
Leukemia, Myeloid, Accelerated Phase--blood
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative--blood
Male
Middle Aged